Abcuro announces pre-clinical data on new immuno-oncology target
Member News
Related or similar articles
June 12, 2019
Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development
The MoU was signed during the official, 40thanniversary celebration ceremony of the Shanghai-Rotterdam Sister City Relationship.
Member News
April 14, 2019
Global 3D Printed Drugs Market Insights 2019-2024 : Extend Biosciences, Bioduro, Affinity Therapeutics
One of the dominating players in the 3D Printed Drugs market is Extend Biosciences
Member News
November 2, 2018
Newton's First Life Sciences Incubator Set To Expand
Longtime biotech executive Jeff Behrens ventured out of the C-Suite earlier this year, opening the first life sciences-focused incubator in Newton. Now he's expanding the project amid broader demand for shared lab space.
Labshares News